State Street’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-19,376
Closed -$283K 4824
2023
Q1
$283K Sell
19,376
-85
-0.4% -$1.2K ﹤0.01% 3946
2022
Q4
$142K Buy
19,461
+91
+0.5% +$642 ﹤0.01% 4244
2022
Q3
$134K Buy
+19,370
New +$145K ﹤0.01% 4321
2021
Q4
Sell
-10,855
Closed -$131K 4829
2021
Q3
$131K Buy
+10,855
New +$123K ﹤0.01% 4483

State Street's AMYT Position: Q2 2023 in Review

State Street sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q2 2023, closing a stake of 19,376 shares — an estimated $283K sold.

State Street first reported a position in AMYT in Q3 2021 and held it in 4 quarters. The position peaked at $283K in Q1 2023. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

  • State Street reported no remaining Amryt Pharma plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
  • State Street sold 19,376 Amryt Pharma plc American Depositary Shares shares in Q2 2023, an estimated $283K.
  • State Street first reported a position in Amryt Pharma plc American Depositary Shares in Q3 2021 and held it in 4 quarters.
  • State Street's Amryt Pharma plc American Depositary Shares position peaked at $283K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q2 2023.

Based on State Street's 13F filing for Q2 2023, filed 14 Aug 2023.